Sharescart Research Club logo ×
Screener Research Buy Unlisted Shares Sell Unlisted Shares Startup Funding New IPO New

Dr. Lal Pathlabs

₹2849 94.3 | 3.4%

Market Cap ₹23868 Cr.

Stock P/E 48.5

P/B 11.3

Current Price ₹2849

Book Value ₹ 252.6

Face Value 10

52W High ₹3645

Dividend Yield 0.84%

52W Low ₹ 2295.1

Overview Inc. Year: 1995Industry: Hospital & Healthcare Services

Dr. Lal PathLabs Ltd is an India-based organisation, that is engaged in offering diagnostic and associated healthcare assessments and offerings. It has a community that have a National Reference Laboratory in New Delhi, a Reference Laboratory in Kolkata and approximately 229 other clinical laboratories. The Company is engaged specially within the enterprise of strolling laboratories for carrying out pathological investigations of diverse branches of biochemistry, haematology, histopathology, microbiology, electrophoresis, immuno-chemistry, and different pathological and radiological investigations. The Company offers various tests by condition, which incorporates allergic reaction, diabetes, health checkups, viral infections, fever, heart sicknesses, high blood pressure, cancer, abortions, anaemia, arthritis, breast cancer, diphtheria, disease of liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular sickness and viral infections.

Read More..

Dr. Lal Pathlabs Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Dr. Lal Pathlabs Quarterly Results

#(Fig in Cr.) Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 489 491 541 601 539 545 602 660 597 603
Other Income 11 14 14 18 18 18 21 22 25 26
Total Income 500 505 555 619 557 564 623 682 622 628
Total Expenditure 376 375 395 424 398 401 432 458 443 434
Operating Profit 124 130 161 196 159 163 191 224 179 195
Interest 9 9 8 8 7 7 6 6 5 5
Depreciation 38 38 35 36 36 37 35 35 36 36
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 77 83 118 152 116 120 150 183 138 153
Provision for Tax 23 26 34 42 34 34 42 52 40 -2
Profit After Tax 54 57 84 111 82 86 108 131 98 156
Adjustments -1 -0 -1 -1 -1 -1 -1 -2 -1 -1
Profit After Adjustments 53 57 83 109 81 85 106 129 97 155
Adjusted Earnings Per Share 6.3 6.8 9.9 13.1 9.7 10.1 12.7 15.5 11.6 18.5

Dr. Lal Pathlabs Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 660 791 912 1057 1203 1330 1581 2087 2017 2227 2461 2462
Other Income 13 22 28 31 46 55 51 53 42 69 93 94
Total Income 673 813 940 1088 1249 1385 1633 2140 2059 2296 2555 2555
Total Expenditure 504 584 675 793 910 987 1145 1527 1527 1617 1766 1767
Operating Profit 168 229 265 295 340 399 488 613 532 678 789 789
Interest 0 0 1 1 1 15 16 30 38 29 22 22
Depreciation 28 28 28 33 38 73 77 108 150 144 142 142
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 140 201 237 261 301 311 394 475 344 505 625 624
Provision for Tax 43 67 81 90 100 83 98 125 103 143 133 132
Profit After Tax 96 133 156 172 200 228 296 350 241 362 492 493
Adjustments -1 -1 -1 -1 -1 -2 -5 -5 -2 -5 -5 -5
Profit After Adjustments 96 132 155 171 199 226 292 345 239 358 487 487
Adjusted Earnings Per Share 16.8 16 18.6 20.5 23.9 27.1 35 41.4 28.6 42.9 58.3 58.3

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 11% 6% 13% 14%
Operating Profit CAGR 16% 9% 15% 17%
PAT CAGR 36% 12% 17% 18%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -2% 9% 11% NA%
ROE Average 25% 21% 23% 26%
ROCE Average 32% 27% 30% 36%

Dr. Lal Pathlabs Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 341 507 596 788 945 1033 1245 1502 1666 1849 2173
Minority's Interest 2 3 2 4 5 21 31 35 33 36 34
Borrowings 0 0 0 0 0 0 0 167 83 0 0
Other Non-Current Liabilities -5 12 -6 -9 -20 70 83 106 93 62 21
Total Current Liabilities 112 91 85 116 138 227 274 500 470 464 402
Total Liabilities 450 613 676 899 1069 1351 1633 2310 2345 2411 2630
Fixed Assets 150 166 152 208 209 413 447 1369 1305 1194 1135
Other Non-Current Assets 18 24 57 68 47 46 41 66 67 91 132
Total Current Assets 282 424 467 623 814 893 1145 875 973 1127 1364
Total Assets 450 613 676 899 1069 1351 1633 2310 2345 2411 2630

Dr. Lal Pathlabs Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 16 23 27 29 66 129 197 244 378 264 361
Cash Flow from Operating Activities 122 159 171 197 219 284 398 447 456 535 569
Cash Flow from Investing Activities -113 -163 -137 -172 -100 -26 -212 -449 -287 -24 -303
Cash Flow from Financing Activities -1 0 -32 13 -55 -190 -139 136 -283 -414 -334
Net Cash Inflow / Outflow 8 -5 2 37 64 67 48 134 -114 97 -68
Closing Cash & Cash Equivalent 23 19 29 66 129 197 244 378 264 361 293

Dr. Lal Pathlabs Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 16.77 15.99 18.61 20.49 23.9 27.11 34.99 41.37 28.65 42.85 58.28
CEPS(Rs) 22.81 19.54 22.05 24.58 28.64 36.04 44.84 55 46.93 60.6 75.87
DPS(Rs) 1.53 2.45 3 4.5 6 12 20 12 12 24 24
Book NAV/Share(Rs) 57.56 61.28 70.66 92.39 110.08 119.97 144.61 173.17 192.88 215.4 253.14
Core EBITDA Margin(%) 23.52 26.24 26.03 24.98 24.4 25.83 27.59 26.86 24.29 27.36 28.26
EBIT Margin(%) 21.24 25.43 26.03 24.8 25.04 24.49 25.95 24.2 18.91 24.02 26.29
Pre Tax Margin(%) 21.18 25.36 25.96 24.72 24.97 23.34 24.94 22.75 17.05 22.7 25.38
PAT Margin (%) 14.62 16.84 17.05 16.25 16.66 17.11 18.75 16.78 11.95 16.27 20
Cash Profit Margin (%) 18.89 20.41 20.07 19.38 19.83 22.58 23.63 21.96 19.4 22.72 25.76
ROA(%) 24.67 25.06 24.13 21.81 20.38 18.81 19.87 17.77 10.36 15.23 19.53
ROE(%) 37.14 32.45 28.45 25.32 23.76 23.74 26.89 26.45 15.8 21.27 25.15
ROCE(%) 48.87 47.43 43.07 37.9 34.78 32.94 36.03 32.67 20.34 27.89 31.53
Receivable days 15.53 15.51 15.62 14.32 14.31 14.35 13.63 13.3 14.14 12.15 12.27
Inventory Days 7.18 6.64 6.49 7.81 8.47 11.73 11.49 8.31 7.81 5.83 5.45
Payable days 87.86 80.66 87.64 95.14 101.04 120.69 120.3 105.92 123.86 138.53 146.09
PER(x) 0 57.63 51.99 42.7 44.12 51.69 77.38 63.02 63.8 52.8 42.52
Price/Book(x) 0 15.04 13.69 9.47 9.58 11.68 18.72 15.06 9.48 10.5 9.79
Dividend Yield(%) 0 0.27 0.31 0.51 0.57 0.86 0.74 0.46 0.66 1.06 0.97
EV/Net Sales(x) -0.1 9.36 8.55 6.6 6.9 8.35 13.68 10.28 7.34 8.15 8.08
EV/Core EBITDA(x) -0.4 32.28 29.42 23.63 24.43 27.87 44.38 34.99 27.86 26.74 25.19
Net Sales Growth(%) 18.22 19.97 15.3 15.84 13.86 10.55 18.86 32.01 -3.38 10.4 10.54
EBIT Growth(%) 17.35 43.6 18.04 10.37 14.96 8.11 25.96 23.09 -24.51 40.24 21
PAT Growth(%) 20.15 38.15 16.78 10.39 16.72 13.53 30.27 18.15 -31.18 50.28 35.87
EPS Growth(%) 17.26 -4.64 16.4 10.09 16.65 13.43 29.07 18.25 -30.75 49.58 35.99
Debt/Equity(x) 0 0 0 0 0 0 0 0.24 0.15 0.05 0
Current Ratio(x) 2.52 4.67 5.5 5.37 5.88 3.93 4.18 1.75 2.07 2.43 3.39
Quick Ratio(x) 2.39 4.51 5.29 5.14 5.68 3.68 4.02 1.65 2 2.35 3.3
Interest Cover(x) 346.2 404.57 340.29 311.72 359.22 21.28 25.65 16.74 10.16 18.22 29.01
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0.02 0.02 0 0

Dr. Lal Pathlabs Shareholding Pattern

# Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Promoter 55.05 55.03 55.01 54.61 54.6 54.6 54.6 53.92 53.91 53.91
FII 25.8 24.89 23.27 24.36 25.35 26.15 25.42 26.82 26.82 23.91
DII 6.19 6.55 8.63 9.14 9.56 9.69 12.71 12.89 13.17 16.08
Public 12.96 13.52 13.1 11.89 10.49 9.56 7.26 6.37 6.11 6.1
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 21%
  • Company is almost debt free.

Cons

  • Debtor days have increased from 138.53 to 146.09days.
  • Stock is trading at 11.3 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Dr. Lal Pathlabs News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....